Boundless Bio (BOLD) Operating Leases (2024 - 2026)
Boundless Bio (BOLD) posted quarterly Operating Leases of $45.0 million for Q1 2026, down 6.85% year-over-year from $48.3 million in Q1 2025, and down 1.88% quarter-over-quarter from $45.9 million in Q4 2025.
Boundless Bio (BOLD) Operating Leases (2024 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Operating Leases for 3 consecutive years, with $45.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 6.85% year-over-year to $45.0 million; the TTM figure through Mar 2026 stood at $45.0 million (down 6.85% YoY), while the FY2025 annual figure was $45.9 million, down 3.7% from the prior year.
- Operating Leases fell to $45.0 million in Q1 2026 per BOLD's latest filing, from $45.9 million in the prior quarter.
- Across five years, Operating Leases topped out at $48.3 million in Q1 2025 and bottomed at $100000.0 in Q3 2024.
- Historically, Operating Leases has averaged $31.5 million across 3 years, with a median of $45.9 million in 2025.
- Annual changes were most pronounced in 2025 — Operating Leases jumped 46607.0% — and 2026, when it dropped 6.85%.
- Boundless Bio's Operating Leases stood at $47.6 million in 2024, then retreated by 3.7% to $45.9 million in 2025, then declined by 1.88% to $45.0 million in 2026.
- Business Quant data shows BOLD's Operating Leases at $45.0 million in Q1 2026, $45.9 million in Q4 2025, and $46.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Boundless Bio | 66.72 Mn | 66.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.00 Mn |
| Dec 31, 2025 | 45.87 Mn |
| Sep 30, 2025 | 46.71 Mn |
| Jun 30, 2025 | 47.55 Mn |
| Mar 31, 2025 | 48.31 Mn |
| Dec 31, 2024 | 47.63 Mn |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 1.50 Mn |